🔬Researchers Develop mRNA Therapy to Reawaken Dormant Immune Cells
New mRNA therapy could turn the tide against aggressive cancers
TL;DR
Researchers have developed an mRNA therapy that can reprogram immune cells to fight cancer. The treatment uses 'smart' nanoparticles to deliver mRNA that produces CXCL9, a chemical signal for recruiting T cells. Early tests in mice with aggressive breast cancer show slowed tumor growth and increased CXCL9 levels.
Researchers have created an mRNA therapy that can reprogram immune cells to fight cancer, potentially overcoming a major barrier for even the most promising cancer treatments. The therapy uses 'smart' nanoparticles to deliver mRNA that produces CXCL9, a chemical signal for recruiting T cells. In mice with aggressive breast cancer, tumor growth slowed after three doses, and CXCL9 levels were four times higher than in the control group. The treatment also reduced immunosuppressive macrophages by 63 percent. While the combination with existing immunotherapies didn't reduce tumor size further, it did increase T cell activity within tumors and nearby lymph nodes. This breakthrough could be a game-changer for patients with aggressive cancers, but more studies are needed to evaluate safety before human trials can begin.
Key Points
The therapy uses 'smart' nanoparticles studded with antibodies that bind to TREM2, a protein on tumor-associated macrophages.
The nanoparticles carry mRNA that produces CXCL9, a chemical signal for recruiting T cells, increasing CXCL9 levels four times higher than in controls.
The treatment reduced immunosuppressive macrophages by 63 percent, potentially reawakening dormant immune cells to fight cancer.
Combination with existing immunotherapies increased T cell activity within tumors and nearby lymph nodes without further reducing tumor size.
More studies are needed to evaluate safety before human trials can begin, but early results are promising for aggressive cancers.
Why It Matters
If you're working on cancer immunotherapy, this mRNA therapy could be a game-changer. It uses 'smart' nanoparticles to deliver mRNA that reprograms immune cells to fight cancer, showing slowed tumor growth and increased CXCL9 levels in mice. The treatment also reduced immunosuppressive macrophages by 63 percent, potentially reawakening dormant immune cells to fight cancer. While more studies are needed, this could be a major breakthrough for patients with aggressive cancers.
Comments
Be the first to comment
Enjoyed this article?
Get it daily. 7am. Free. Reads in 5 minutes.
Join 3,482 builders reading daily.